SciELO - Scientific Electronic Library Online

 
vol.49 número1Alteraciones morfológicas en el músculo esquelético de ratas espontáneamente hipertensas.Presentación de un caso de sarcoma maligno laríngeo, tratado mediante laringotomía transversa y revisión de la literatura índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Investigación Clínica

versión impresa ISSN 0535-5133versión On-line ISSN 2477-9393

Invest. clín v.49 n.1 Maracaibo mar. 2008

 

Evaluation of the OptiMAL® test for diagnosis of malaria in Venezuela. 

Noraida Zerpa1, Rosalba Pabón2, Albina Wide3, Magda Gavidia4, Mehudi Medina4, José Luis Cáceres5, Jacinta Capaldo2, Meghan Baker6 and Oscar Noya2,3

1 Fundación Instituto de Estudios Avanzados (IDEA), Centro de Biociencias, Sartenejas,

2 Laboratorio para Estudios sobre Malaria-IAESP “Arnoldo Gabaldon”,

3 Cátedra de Parasitología, Escuela de Medicina “Luis Razetti”, Facultad de Medicina, Universidad Central de Venezuela. Caracas,

4 Ministerio de Salud, Dirección General de Salud Ambiental

5 Facultad de Ciencias de la Salud, Universidad de Carabobo, Maracay. Venezuela.

6 Massachusetts General Hospital and Brigham and Women’s Hospital, Department of Infectious Diseases, Boston, Massachussets, USA.

Corresponding author: Noraida Zerpa. Fundación Instituto de Estudios Avanzados (IDEA), Centro de Biociencias. Sartenejas, Caracas, Venezuela. E-mail: norazerpa@yahoo.com

Abstract.

We evaluated the OptiMAL® rapid dipstick test by comparing it with the conventional standard thick-blood film method, for the detection of malaria in two groups of individuals from different Venezuelan endemic areas. One of the groups consisted of individuals with malaria-like symptoms (n = 113) and the other of asymptomatic individuals (n = 89). The classical microscopy analysis of these populations determined that 67.5% were infected with P. vivax, 31.3% with P. falciparum, and 1.2% with mixed infections. The OptiMAL® test showed 96.4% sensitivity, 100% specificity, 100% positive predictive value, 97.5% negative predictive value and optimal concordance (kappa = 0.97), capable of detecting any malaria infection in the evaluated population. However, these parameters were lower when the parasitaemia was £ 300 parasites/µL. Freezing of the samples did not affect the sensitivity and specificity of the test. We concluded that this rapid malaria test is sensitive and specific for rapid diagnosis of malaria in the field and it is a complement to conventional microscopy.

Key words:  OptiMAL®, Plasmodium falciparum,Plasmodium vivax, parasitaemia.

Evaluación de la prueba OptiMAL® para el diagnóstico de la malaria en Venezuela.

Resumen.

Se evaluó el test rápido OptiMAL® comparándolo con el examen convencional de observación de muestras sanguíneas para la detección de la malaria en dos grupos de individuos procedentes de diferentes áreas endémicas de Venezuela. Uno de los grupos (n = 113) con síntomas sugestivos de malaria, y otro representado por individuos asintomáticos (n = 89). El examen microscópico de las muestras de sangre de estas poblaciones determinó que 67,5% estaban infectados con P.vivax, 31,3% con P. falciparum y 1,2% con infecciones mixtas. La prueba OptiMAL® mostró 96,4% de sensibilidad, 100% de especificidad, con valor predictivo positivo de 100% y valor predictivo negativo de 97,5%. La detección de cualquier infección malárica en la población total presentó una concordancia óptima (kappa = 0,97). Sin embargo, estos parámetros fueron más bajos cuando la parasitemia era £ 300 parásitos/µL. El congelamiento de las muestras no afectó la sensibilidad y especificidad de la prueba. Nosotros concluimos que esta prueba rápida de malaria es sensible y especifica para el diagnóstico rápido de la malaria en el campo y puede complementar a la microcopia convencional.

Palabras clave:  OptiMAL®, Plasmodium falciparum, Plasmodium vivax, parasitemia. 

Received: 30-01-2007. Accepted: 03-07-2007.

INTRODUCTION

Malaria causes more than three hundred million acute infections and it kills at least one million people every year. Ninety percent of deaths due to malaria take place in Sub-Saharan Africa and most of them in children under the age of five (1). There are around 45,000 cases of malaria per year in Venezuela, with the highest prevalence in Bolivar and Sucre states. The classical chosen method for detection of the malaria parasite is the examination of Giemsa-stained thick and thin blood films. This method allows to estimate parasitaemia, to distinguish between parasite growth stages and to identify the four different Plasmodium species. However, it has certain limitations, the need for trained staff and specialized equipments, which have stimulated the development of new diagnostic methods suitable for field conditions. Other non-microscopical diagnostic techniques have been developed. These methods include different PCR-based techniques like PCR and RT-PCR. The detection limits of these methods (2.5 to 10 parasites/µL) are similar to those provided by light microscopy, but in general, they are technically difficult to perform and their use is restricted to reference centers (2-6). Other techniques for the laboratory diagnosis of malaria have been developed to be used in endemic and non-endemic areas such as the immunodiagnostic methods. These are based on antibody capture of circulating antigens from Plasmodium spp, demonstrating them to be fast and reliable. Bearing in consideration the need to develop and to adapt reliable and simple techniques to be used in the field, we considered that the simplest and more suitable test for field use is the immunochromatographic strip test. There are three methods based on the capture of histidine-rich protein (HRP2): Two test use Ig G monoclonal antibody, the ParaSight™-F (Beckton and Dickinson) (7) and Now® ICT™ Malaria Pf/Pv (Binax, Inc., Portland, ME), which capture Plasmodium aldolase, in addition to the HRP2 protein (8) and, PATH Falciparum Malaria IC test (9), that uses Ig M monoclonal antibody, which binds to the HRP2 antigen.

The OptiMAL® Rapid Malaria test (Flow Inc, Portland, Org) is an immunochromatographic assay that uses monoclonal antibody-coated strips to detect parasite lactate dehydrogenase (pLDH) in blood (10, 11). There is no cross-reaction with human LDH (12). This test can be performed in less than 20 minutes and does not require highly trained personnel. An advantage of the OptiMAL® test is that it detects only live parasites, thereby providing a sensitive mean of monitoring treatment (13, 14). Prompt treatments depend on immediate and accurate malaria diagnosis. Our objective was to evaluate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPP) of the OptiMAL® rapid test in comparison with standard microscopy for diagnosis of malaria caused by P. falciparum and P. vivax in two regions from Venezuela.

MATERIALS AND METHODS

Study areas and populations

This study was conducted from January to May 2000 in endemic areas from Bolivar and Sucre states, Venezuela. Two sets of patients were used, one of them (n = 113) was referred from the diagnostic center “Dr. Francesco Vitanza”, Tumeremo, Bolivar state, with malaria-like symptoms. The other group consisted of asymptomatic individuals (n = 89), residents from Yaguaraparo, Sucre state, chosen by random active seeking in a cross sectional study. They correspond to individuals with no symptoms for at least 30 days and who had not taken any anti-malarial drugs, as demonstrated by thin layer chromatography of urine samples. Bolivar state is a well known endemic area for malaria in Venezuela (9,252 cases for year 2000), being P. vivax the most prevalent species (72.4%) at the time of the study, followed by P. falciparum (27.6%). Sucre state is also an endemic area (12,255 cases for year 2000) being P. vivax the prevalent species. Eligible subjects were more than 20 years old and provided consent for inclusion in this study. This research was approved and conducted under the supervision and support of the Venezuelan Ministry of Health and Social Development (MSDS).

Sample collections

Whole blood samples were taken, ear-tagged for thick and thin blood preparations and collected into EDTA-coated capillary tubes for the OptiMAL® test which was performed immediately. The thick and thin smears were processed within 30 minutes of sample collection. A limited number of samples were taken by venopuncture from 48 patients who agreed to donate 5 mL of blood, which were frozen in liquid nitrogen for further testing at the laboratory.

Malaria diagnosis with thin and thick blood smears

Slides were stained with freshly prepared 10% (v/v) Giemsa solution for 15 minutes, examined for the presence of parasites and blindly compared against the results from the rapid diagnostic test. Slides were re-examined in the same way by two independent expert readers in the laboratory. Parasitaemia was measured by counting the number of asexual parasites against 500 leukocytes on the thick blood film assuming an average of 8000 white blood cells (WBC)/µL (15). Smears were considered negative if no parasites were found in 500 fields (1000 × magnification) on a thick blood film.

Malaria diagnosis with OptiMAL

The OptiMAL® test (DiaMed SA, 1785, Cressier sur Morat, Switzerland under license from Flow, Inc, Portland, OR 97201, USA) was performed following the manufacturer’s instructions. Briefly, one drop of whole blood was mixed with two drops of lysis buffer A, which disrupts the red blood cells and releases the pLDH. The specimens were then allowed to migrate to the top of the pLDH strip. After eight minutes, the strips were placed in washing buffer B, which separated the hemoglobin from the strip. The test results were read immediately. Negative control samples were taken from an individual who had not been exposed to malaria for three years, and included within each batch tested. The assay has an internal control band at the top, a pan-Plasmodium-specific band in the middle (which also recognizes the pLDH isoform from P. vivax), and a P. falciparum- specific band at the bottom. The test was completed in 10-15 minutes. All dipstick tests were performed blindly with respect to results from other diagnostic tests.

Data analysis

Sensitivity was calculated as true positives/(true positives + false negatives) and specificity as true negatives/(true negatives + false positives). Sensitivity and specificity were determined at different levels of parasitaemia. Positive and negative predictive values were calculated based on the prevalence of Plasmodium spp (or malaria parasite) during the study. The (kappa) statistic method was used to measure agreement between the tests. This represents the proportion of agreement between observation and chance: a value of 1 indicates perfect agreement, and 0 indicates agreement than would be expected to occur on the basis of chance alone (16).

The statistical analysis were conducted with SPSS 7.5 for WindowsÒ and Epi-Info 6.04

RESULTS 

A total of 202 individuals were investigated for malaria parasites by microscopy in Giemsa-stained blood smears, and 83 (41.1%) were found to be positive (78 symptomatic and 5 asymptomatic). From these, 56 (67.5%) were infected with P. vivax, 26 (31.3%) with P. falciparum and 1 (1.2%) mixed infection (Table I). On the other hand, the OptiMAL® test identified malaria infection in 80 (39.6%) individuals. From these, 56 (70.0%) had P. vivax infection and 23 (28.8%) had P. falciparum infection. Microscopy identified 3 cases of P. falciparum and one mixed (1.2%) infection that the OptiMAL® test could not discriminate (Table II). Two independent expert microscopists identified the same number of positive and negative blood films for malaria (data not shown).

TABLE I

SUMMARY OF FINDINGS IN SUSPECTED MALARIA INDIVIDUALS (SYMPTOMATICS) AND ASYMPTOMATICS FOR MICROSCOPY AND THE OptiMAL® TEST AT THE HEALTH SERVICE IN ENDEMIC AREAS AND CENTRAL LABORATORY 

 

            Microscopy

OptiMAL® 

Health service in endemic area 

Central Laboratory 

Health service in endemic area 

Symptomatics 

    P. vivax 

    P. falciparum 

    Mixed infections 

    Negatives 

 

54 

27 

30 

 

51 

26 

35 

 

51 

23 

ND 

38 

Positive 

Negative 

83/113 

30/113 

78/113 

35/113 

75a/113 

38/113 

Asymptomatics 

    P. vivax 

    P. falciparum 

    Mixed infections 

    Negatives 

 

84 

 

84 

 

84 

Positive 

Negative 

5/89 

84/89 

5/89 

84/89 

5/89 

84/89 

TOTAL 

202 

202 

202 

aInclude one mixed infection not discriminated of P. falciparum infection.    ND: Not discriminated.

TABLE II

COMPARATIVE PERFORMANCE OF THE OptiMAL® TEST IN SUSPECTED MALARIA PATIENTS AND ASYMPTOMATIC INDIVIDUALS AT HEALTH SERVICE IN ENDEMIC AREAS AND CENTRAL LABORATORY WITH MICROSCOPY 

 

OptiMAL® 

  Microscopy at Health Service in endemic area 

Microscopy Central Laboratory*

Positive 

Negative 

Total 

Positive 

Negative 

Total 

Positive 

80 

  0 

 80 

 80a 

  0 

 80 

Negative 

 8 

114 

122 

 3 

119 

122 

TOTAL 

88 

114 

202 

83 

119 

202 

aMixed infections are included.  * Sensitivity: 96.4%.   Specificity: 100%.     PPV: 100%.  PNV: 97.5%.  k: 0.97.

Based on microscopy results, the OptiMAL® test showed 96.4% sensitivity (S), and 100% specificity (E). The Positive Predictive Value (PPV) was 100 % and the Negative Predictive Value (NPV) was 97.5%, with optimal concordance (kappa = 0.97) for detection of any malaria infection in the total population. No false-positive results were observed. Results for P. falciparum infections were: sensitivity 88.5%, specificity 100%, PPV 100%, and NPV 98.3%, with optimal concordance (k = 0.93). Meanwhile, results for P. vivax infections were: 100% sensitivity, specificity, PPV and NPV and perfect concordance (k = 1). In symptomatic patients, the sensitivity was 96.1%, specificity 100%, PPV 100% NPV 92.1% and optimal concordance (kappa = 0.93) (Table II). However, in the asymptomatic individuals, the same indicators were 100% with perfect concordance (k = 1). The OptiMAL® and microscopy results for sensitivity, specificity, PPV and NPV at various levels of parasitaemia are shown in Table III. The OptiMAL® test did not detect the lowest level of parasitaemia (64, 73 and 200 parasites/µL) for P. falciparum infections, the minimum level of parasitaemia detected was 240 parasites/µL. In order to evaluate the effect of freezing on the OptiMAL® test, blood samples were frozen and stored for 30 days. The OptiMAL® test results were compared with fresh samples and did not show differences for both conditions: sensitivity (97.7%), specificity (100%), PPV (100%) and NPV (75.0%), with optimal concordance (k = 0.86).

TABLE III

PARASITE LEVELS DETECTED BY THIN-THICK SMEAR AND THE OptiIMAL® TEST 

Parasites/µL 

N° of positives by thick and thin smears 

N° of Positives by OptiMAL® 

Sensitivity

 

Specificity 

PPV 

NPV 

100 

 2 

 0 

0.0 

100 

100 

99.0 

101-200 

 1 

 0 

0.0 

100 

100 

99.5 

201-300 

 6 

 5 

83.0 

100 

100 

99.4 

301-400 

 2 

 2 

100 

100 

100 

100 

401-500 

 2 

 2 

100 

100 

100 

100 

>500 (640-41,339) 

70 

70 

100 

100 

100 

100 

Total 

83 

79 

95.0 

100 

100 

96.7 

DISCUSSION 

This study compares the performance of the OptiMAL® test with standard microscopy in patients with suspected malaria and asymptomatic individuals from different regions of Venezuela. The OptiMAL® assay demonstrated 100% sensitivity for P. vivax and 88.5% for P. falciparum infections in the evaluated populations. The estimated prevalence of malaria infection, evaluated by this method, was 39.6%. The sensitivity of the method decreases when the infection was under 300 parasites/µL. Studies conducted in Pakistan by Igbal et al., (17) found that OptiMAL® had a sensitivity, PPV and PNV values considerably lower for P. vivax infections than for P. falciparum infections. In our study, the concordance between the OptiMAL® test and microscopy for detecting P. vivax infections in asymptomatic individuals was excellent. The reason for this result is that these individuals had high parasitaemia (280-5,640 parasites/µL). Similar results have been found in other studies conducted in our laboratory (unpublished data). However, Coleman et al. (18) reported the combination of poor assay specificity and low sensitivity in asymptomatic individuals with parasite densities <500/µL with the same method. Incorporation of more sensitive tests for detecting low parasite densities, like PCR, could support the results obtained with the OptiMAL® method, as shown previously (19, 20).

Studies from Brazil have reported good sensitivity when parasitaemia was greater than 250 parasites/µL for P.vivax and greater than 400 parasites/µL for P. falciparum (21). Lower sensitivity (88.2-92.0%) for detecting infections with 500-1000 parasites/µL, and even lower sensitivity for detecting infections with less than 500 parasites/µL, has been reported in studies conducted in Gambia (22), Indonesia (23), Colombia (24), Peru (25), and Mexico (26). Differences in the sensitivity observed in these studies can be explained by the following: 1. expertise of the microscopist to detect and to differentiate between infections; 2. differences in the methods to estimate parasite density and 3. immunity due to previous exposure. Since circulating malaria antigens could be complexed to antibodies, they might not be available for immunocapture by the two antibodies present in the diagnostic strip. However, we did not obtain evidence from sample populations to suggest that pre-existing anti-pLDH antibodies interfered with OptiMAL in detecting malaria. It is important to note that sample freezing did not affect the performance of the OptiMAL® test. This result provides evidence of pLDH stability as a target for malaria diagnosis.

Microscopy identified 3 cases of P. falciparum and one mixed infections that the OptiMAL® test could not discriminate it. It is possible that low levels of parasitaemia in those patients (£ 200 parasites/µL) correspond to low pLDH blood concentrations, which are probably within the sensitivity limits of the test, resulting in failure to capture the antigen by the monoclonal antibody present in the dipstick. Another reason could be the retention of parasites in the endothelium of capillary vessels (27) or the presence of pLDH as immune complexes avoiding its capture by MAbs.

The OptiMAL® test was very sensitive for detecting P. vivax in populations with co-endemic P. falciparum and P.vivax infections. However, in mixed infections, this method did not discriminate P. falciparum because of cross-reactivity by the pan-specific band. The inability to distinguish mixed P. falciparum infections with the OptiMAL® dipstick test limits its clinical use, especially in areas where drug resistance is prevalent. Therefore, the sensitivity of the test depended more on the density of parasites than on the species present.

The concordance found between the OptiMAL® test and microscopy for detecting P. vivax infections in asymptomatic conditions was excellent. However, in other studies, the OptiMAL® showed markedly less sensitivity than microscopy for detecting infections in asymptomatic people (17). These results suggest that the immunochromatographic test may be a useful epidemiological tool for early detection and treatment of malaria, particularly in areas where P. vivax gametocytes appear at the onset of the infection and the risk of transmission appears earlier than in P. falciparum infections. Regarding to symptomatic patients, the OptiMAL® test provides an easier, rapid, objective and applicable alternative for most remote endemic areas lacking specialized laboratory facilities and personnel (17), allowing early treatment and avoiding complications. This is particularly true in P. falciparum-infected patients, which can be negative by microscopy due to the parasites being kept at the vascular endothelium (27). We are aware that, although this test should not replace conventional microscopy, it is a valuable tool as a complementary diagnosis for malaria in the field and at the laboratory.

ACKNOWLEDGMENTS

We thanks the Ministry of Health and Social Development MSDS, and the Rural Endemic Services from Bolivar and Sucre states for allowing access and given support to this study. We also thanks, the Francesco Vitanza Research Center from Tumeremo, Bolivar State, where some assays were carried out. Partial support for travel expenses was provided by DiaMed SA, Cressier sur Morat, Switzerland. The presentation of these results in national and international meetings was sponsored by FONACIT.

REFERENCES 

1. WHO/TDR Malaria Database (http://www. wehi.edu.au/MalDB-www/intro.html).        [ Links ]

2. Snounou G, Bourne T, Jarra W, Viriyakosol S, Wood JC, Brown KN. Assessment of parasite population dynamics in mixed infections of rodent plasmodia. Parasitology 1993; 105:363-374.        [ Links ]

3. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993; 58:283-292.        [ Links ]

4. Ndao M, Bandyayera E, Kokoskyn E, Gyorkos TW, Mac-Leen JD, Ward BJ. Comparison of blood smear antigen detection and Nested PCR methods for screenning refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada. J Clin Microbiol 2004; 42:2694-2700.        [ Links ]

5. Siribal S, Nakasiri S, Louareesuwai S, Chavalishewinkoon-Pelmirti P. Identification of human malaria parasites and detection of mixed infection in Thai patients by nested PCR. South Asian J Trop Med Public Health 2004; 35:5-9.        [ Links ]

6. Malhotra I, Dent A, Mungui P, Muchiri E, King CL. Real-time quantitative PCR for determining the burden of Plasmodium falciparum parasites during pregnancy and infancy. J Clin Microbiol 2005; 43:3630-3635.        [ Links ]

7. Shiff C, Premji Z, Minjas JN. The rapid manual ParaSight-F test. A New diagnostic tool for Plasmodium falciparum infections. Trans R Soc Trop Med Hyg 1993; 87:646-648.        [ Links ]

8. Moody A. Rapid diagnostic test for malaria parasites. Clin Microbiol Rev 2002; 15: 66-78.        [ Links ]

9. Mills CD, Burgess DC, Taylor HJ, Kain C. Evaluation of a rapid and inexpensive dipstck assay for the diagnosis of Plasmodium falciparum malaria. Bull World Health Organ 1999; 77:553-559.        [ Links ]

10. Piper R, Vander-Jagt DL, Holbrook JJ, Makler M. Malaria lactate dehydrogenase target for diagnosis and drug development. Ann Trop Med Parasitol 1996; 90:433.        [ Links ]

11. Piper R, Lebras J, Wentworth L, Hunt-Cooke A, Houze S, Chiodini P, Makler M. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase(pLDH). Am J Trop Med Hyg 1999; 60:109-118.        [ Links ]

12. Makler MT, Hindrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitaemia. Am J Trop Med Hyg 1993; 48 (2):205-210.        [ Links ]

13. Palmer CJ, Lindo JF, Klaskala WI, Quesada JA, Kaminsky R, Baum MK, Ager AL. Evaluation of the OptiMAL Test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum Malaria. J Clin Microbiol 1998; 36:203-206.        [ Links ]

14. Vanderjagt TA, Ikeh FI, Ujah OA, Belmonte J, Glew RH, Vanderjagt DJ. Short communication: Comparison of the OptiMAL rapid test and microscopy for detection of malaria in pregnant women in Nigeria. Trop Med Int Health 2005; 10 (1):39-41.        [ Links ]

15. Warhurst DC, Williams JE. Laboratory diagnosis of malaria. J Clin Path 1996; 49: 533-538.        [ Links ]

16. Fleiss JL. The measurement of interrater agreement. In: Statistical methods for rates and proportions, 2nd ed. New York, John Wiley & Sons; 1981, p 212-236.        [ Links ]

17. Iqbal J, Muneer A, Khalid N, Ahmed MA. Performance of the OptiMal test for malaria diagnosis among suspected malaria patients at the rural health centers. Am J Trop Med Hyg 2003; 68(5): 624-628.        [ Links ]

18. Coleman RE, Maneechar N, Ponlawat A, Kumpitak C, Rachapaew N, Miller RS, Sattabongkot J. Short report: Failure of the OptiMAL® rapid Malaria test as a tool for the detection of asymptomatic malaria in an area of Thailand endemic for Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 2002; 67(6):563-565.        [ Links ]

19. Wide A, Pabón R, De Abreu N, Pérez H, Noya O. Detección de portadores asintomáticos de Plasmodium vivax en el municipio Cagigal estado Sucre, Venezuela. Parasitol Latinoamer 2005; 60(1-2):225.        [ Links ]

20. Rodulfo H, De Donato M, Mora R, Gonzalez I, Contreras CM. Comparison of the diagnosis of malaria by microscopy, immunochromatography and PCR in endemic area of Venezuela. Brazilian J Med and Biol Res 2007; 40:535-543.        [ Links ]

21. De Sousa-Rodrigues R, Fugikaha E, Lorenzetti A, Tomé-Alves R, Cavasini C, Baptista Rossi A, Pachiano-Calvosa V, D’Almeida-Couto A, Dantas-Machado R. Evaluation of an immunochromatographic test for malaria diagnosis under different storage conditions. Rev Soc Bras Med Trop 2005; 38:94-195.        [ Links ]

22. Hunt-Cooke A, Chiodini PL, Doherty T, Moody AH, Ries JP. Comparison of a parasite lactate dehidrogenase-based immunochromatographic. Antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasite in human blood samples. Am J Trop Med Hyg 1999; 60: 173-176.        [ Links ]

23. Fryauff DJ, Purnomo S, Sutamihardja MA, Elyazar IR, Krisin IS, Subianto B, Marwoto H. Performance of the OptiMAL® assays for detection and identification of malaria infection in asymtomatic residents of Irian Jaya, Indonesia. Am J Trop Med Hyg 2000; 63:139-145.        [ Links ]

24. Ferro BE, González IJ, Carvajal de F, Palma GI, Sarabia NG. Performance of OptiMAL® in the diagnosis of Plasmodium vivax and Plasmodium falciparum infections in a malaria Referral Center in Colombia. Mem Inst Oswaldo Cruz 2002; 97:731-735.        [ Links ]

25. Soto-Tarazona A, Solari-Zerpa L, Mendoza-Requena D, Llanos-Cuentas A, Magill A. Evaluation of the rapid diagnostic test OptiMAL for diagnosis of malaria due to Plasmodium vivax. Braz J Infect Dis 2004; 8:151-155.        [ Links ]

26. González-Cerón I, Rodríguez MH, Betanzos AF, Abadia A. Efficacy of a rapid test to diagnose Plasmodium vivax in symptomatic patients of Chiapas, México. Salud Pública Mex 2005; 47:282-287.        [ Links ]

27. Simalut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, Simpson JA, Hien TT, White NJ. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999; 155:395-410.        [ Links ]

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons